Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses

International Immunology

Volumn 13, Issue 11, 2001, Pages 1361-1371

  Monzavi Karbassi, Behjatolah ^a   Cunto Amesty, Gina ^a   Luo, Ping ^a   Shamloo, Shahram ^a   Blaszcyk Thurinl, Magdalena ^b   Kieber Emmons, Thomas ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Cancer vaccine; Carbohydrate; L selectin; Meth A cells; Peptide mimeotope

Indexed keywords

CARBOHYDRATE; CARBOHYDRATE ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GLYCOPEPTIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; L SELECTIN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; SELECTIN; SIALYLATED LEWIS A ANTIGEN; SIALYLATED LEWIS X ANTIGEN; SUGAR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL; ANTIGEN EXPRESSION; ARTICLE; ASSOCIATION; CELL ACTIVITY; CELL POPULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HELPER CELL; IMMUNIZATION; IN VITRO STUDY; INTERFERON PRODUCTION; METASTASIS; METHYLCHOLANTHRENE INDUCED FIBROSARCOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; SENSITIVITY AND SPECIFICITY; STIMULATION; TUMOR; TUMOR CELL; TUMOR REJECTION;

EID: 0035169023     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.11.1361     Document Type: Article

References (60)

1. Cell surface carbohydrates as prognostic markers in human carcinomas
2. Comparison of 16 human colon carcinoma cell lines for their expression of sialyl LeX antigens and their E-selectin-dependent adhesion
3. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-a clinicopathologic study
4. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines
5. Sialyl-Lewis x and sialyl-Lewis a are associated with MUC1 in human endometrium
6. Expression of Lewis X-related antigens in adenocarcinomas of lung
7. Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma
8. Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens
9. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases
10. Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer
11. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis
12. The role of sialylated Lewis antigens on hematogenous metastases of human pancreas carcinoma cell lines in vivo
13. Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area
14. Expression of L-selectin ligands by transformed endothelial cells enhances T cell-mediated rejection
15. E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers
16. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis x to adhesion of human cancer cells to vascular endothelium
17. Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma
18. Dual roles of sialyl Lewis x oligosaccharides in tumor metastasis and rejection by natural killer cells
19. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses
20. Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development
21. Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anticarbohydrate antibody response
22. + T cell response
23. h1 cells is regulated by IL-12
24. Mechanisms of L-selectin regulation by activated T cells
25. Lectin purified human class I MHC-derived peptides: Evidence for presentation of glycopeptides in vivo
26. Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo
27. b/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity
28. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
29. Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine
30. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo
31. Sequential T cell response involved in tumor rejection of sarcoma, Meth A, in syngeneic mice
32. + cytotoxic T lymphocyte
33. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
34. Peptide binding and presentation by mouse CD1
35. MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions
36. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ
37. + T cells
38. Characterization of a T cell line specific to an anti-Id antibody related to the carbohydrate antigen, sialyl SSEA-1, and the immundominant T cell antigenic site of the antibody
39. h1 in tumor lesions
40. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia
41. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma
42. + tumor-draining lymph node cells involved in mediating tumor regression
43. h-1-type cytokine response mediates early tumor regression
44. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity
45. Minimal sulfated carbohydrates for recognition by L-selectin and the MECA-79 antibody
46. Subsets of sialylated, sulfated mucins of diverse origins are recognized by L-selectin. Lack of evidence for unique oligosaccharide sequences mediating binding
47. Endothelial ligands for L-selectin: From lymphocyte recirculation to allograft rejection
48. Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation
49. b-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells
50. Carbohydrates and antigen recognition by T cells
51. T-cell recognition of tumor-associated carbohydrates: The nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity
52. Peptide anchor residue glycosylation: Effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition
53. T cell recognition of Tn-glycosylated peptide antigens
54. Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide
55. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells
56. Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL
57. Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes
58. Superantigens but not mitogens are capable of inducing upregulation of E-selectin ligands on human T lymphocytes
59. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria
60. Cellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens [sialyl Le(a), sialyl Le(x), GD3 and GM2] better than soluble lysate cancer vaccine